Asia-Pacific Genomic Biomarker Market Size, Share and Forecast 2019-2025Posted by Avinash on February 20th, 2020 The Asia-Pacific genomic biomarker market is estimated to grow significantly at a CAGR of over 16% during the forecast period. Asia-Pacific is both a strong and promising market for genomic biomarkers market. This is particularly due to the strong population base, high prevalence of chronic diseases such as cancer and CVDs in Asian countries such as China, Japan, and India. China has a strong market for genomic biomarkers due to huge government investments in R&D and life science projects, the prevalence of chronic diseases such as cancer and the increasing adoption of personalized medicine. All these factors are contributing to the growth of the genomic biomarker market in China. Request a Free Sample of our Report on Asia-Pacific Genomic Biomarker Market: https://www.omrglobal.com/request-sample/asia-pacific-genomic-biomarkers-market The Asia-Pacific genomic biomarker market is segmented on the basis of application and end-user. On the basis of application, the market is segmented into oncology, cardiology, neurology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. On the basis of end-user, the market is segmented into hospitals and diagnostic. Further, the report covers the country-level analysis of the genomics biomarker market in Asia-Pacific. The major economies covered in the report include China, Japan, India and the Rest of Asia-Pacific. A full Report of Asia-Pacific Genomic Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-genomic-biomarkers-market Some of the major players in the Asia-Pacific genomic biomarker market include Thermo Fisher Scientific, inc., Astellas Pharmaceutical Inc., Evotec AG, Qiagen NV, Novartis AG, and others. These companies are launching innovative products in the market, in order to meet the increasing demand for an effective diagnostic biomarker for cancer and cardiovascular diseases. Furthermore, the market players are adopting various strategies, in order to sustain in the competitive market, which includes partnership and collaboration, and investments. Market Segmentation Asia-Pacific Genomic Biomarker Market by Application
Asia-Pacific Genomic Biomarker Market by End-User
Regional Analysis
Company Profiles
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |